Parth Modi to Prostate-Specific Antigen
This is a "connection" page, showing publications Parth Modi has written about Prostate-Specific Antigen.
Connection Strength
1.990
-
Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints. Eur Urol. 2020 08; 78(2):161-162.
Score: 0.629
-
Tradeoffs in Refining the Diagnosis of Prostate Cancer. Eur Urol. 2018 12; 74(6):729-730.
Score: 0.550
-
Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen. Curr Urol Rep. 2010 Jul; 11(4):224-7.
Score: 0.315
-
Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative? Eur Urol. 2022 08; 82(2):161-162.
Score: 0.178
-
Searching for the value of accountable care organizations in cancer care. Cancer. 2018 11 15; 124(22):4287-4289.
Score: 0.141
-
Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Prostate. 2011 Mar 01; 71(4):394-402.
Score: 0.080
-
Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation. Cancer. 2020 12 01; 126(23):5114-5123.
Score: 0.040
-
Long-Term Outcomes of Using Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier Film on the Neurovascular Bundle. J Endourol. 2016 06; 30(6):709-13.
Score: 0.030
-
Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer. Clin Genitourin Cancer. 2016 Feb; 14(1):e1-8.
Score: 0.028